Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sensory masking flavors to improve palatability of rebamipide mouthwash in head and neck cancer
jRCT1030250292Recruiting
- Sponsor
- University of Yamanashi Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of rebamipide in Pharyngeal Neoplasms and head and neck cancer (HNC), sponsored by University of Yamanashi Hospital. Primary endpoint: Overall taste evaluation. Started Aug 2025; status: recruiting.
02
Drugs
rebamipide
03
Conditions
Pharyngeal Neoplasmshead and neck cancer (HNC)
Beyond the preview
Go deeper on jRCT1030250292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030250292.